In addition, unlike genetic deletion, the temporary treatment of Akt inhibitor might further limit the potential carcinogenesis, which is consistent to the conclusion that the transiently MK-2206-treated mice have shown no obvious signs of HCC emergence [88]. Here, AKT1 is linked to hepatocellular carcinoma.